Pulmonx (LUNG) Current Assets (2019 - 2025)

Pulmonx (LUNG) has 7 years of Current Assets data on file, last reported at $101.7 million in Q4 2025.

• Current Assets for Q4 2025 came in at $101.7 million, down 25.37% year-over-year; the trailing twelve-month figure through Dec 2025 was $101.7 million (down 25.37% YoY), and the FY2025 annual result was $101.7 million, down 25.37% from the prior year.
• Current Assets eased to $101.7 million in Q4 2025 per LUNG's latest filing, from $111.2 million in the prior quarter.
• Over five years, Current Assets peaked at $239.3 million in Q1 2021 and troughed at $101.7 million in Q4 2025.
• A 5-year average of $166.3 million and a median of $157.4 million in 2023 frame the typical range for Current Assets.
• The sharpest annual moves came in 2021 and 2025: Current Assets surged 309.27% in 2021, then declined 25.37% in 2025.
• A 5-year view of Current Assets shows it stood at $208.0 million in 2021, then retreated by 18.77% to $169.0 million in 2022, then slipped by 10.97% to $150.4 million in 2023, then dropped by 9.42% to $136.2 million in 2024, then declined by 25.37% to $101.7 million in 2025.
• Business Quant data shows LUNG's Current Assets at $101.7 million in Q4 2025, $111.2 million in Q3 2025, and $120.0 million in Q2 2025.